Showing 1 - 10 of 21
Persistent link: https://www.econbiz.de/10001507984
From the viewpoint of regulation, this paper investigates the effects of both the Health Care Refonn Act (Gesundheitsreformgesetz, GRG) and the Structural Health Care Act (Gesundheitsstrukturgesetz, GSG) on phannaceutical markets. Apart from the change in the intensity of regulation, the main...
Persistent link: https://www.econbiz.de/10010299684
Persistent link: https://www.econbiz.de/10001193729
Persistent link: https://www.econbiz.de/10001313678
From the viewpoint of regulation, this paper investigates the effects of both the Health Care Refonn Act (Gesundheitsreformgesetz, GRG) and the Structural Health Care Act (Gesundheitsstrukturgesetz, GSG) on pharmaceutical markets. Apart from the change in the intensity of regulation, the main...
Persistent link: https://www.econbiz.de/10011622821
From the viewpoint of regulation, this paper investigates the effects of both the Health Care Refonn Act (Gesundheitsreformgesetz, GRG) and the Structural Health Care Act (Gesundheitsstrukturgesetz, GSG) on phannaceutical markets. Apart from the change in the intensity of regulation, the main...
Persistent link: https://www.econbiz.de/10008567512
Persistent link: https://www.econbiz.de/10011696649
Persistent link: https://www.econbiz.de/10003770660
Persistent link: https://www.econbiz.de/10003449600